SkyePharma gets U.S. Solaraze approval

SkyePharma (LSE:SKP; SKYE) received FDA marketing approval for Solaraze, a topical gel using SKP's Hyaluronan Induced Targeting delivery technology to treat actinic keratoses. The product is approved ...